Curr Opin Physiol
Taken together, the figure highlights a key mechanistic principle underlying the therapeutic rationale for multi-agonist strategies: while GLP-1R monotherapy achieves meaningful metabolic and hepatic benefits exclusively through indirect, systemic pathways, the addition of GIPR and - most importantly - GCGR co-agonism introduces complementary and increasingly direct hepatic mechanisms, providing the pharmacological basis for the superior efficacy observed with dual and triple agonists in MASLD/MASH
Parnham also expressed hesitation about the way Sikiric presented the data, describing him as wielding flashy slides with too much certainty, like a marketing pitch. At the end of 2009, the licensing rights to BPC-157 were returned to Sikiric, along with all of the data that PLIVA had generated
Before treatment, his CGM showed: frequent glucose spikes after meals a persistently elevated baseline glucose , even between meals and overnight This pattern suggests prolonged glucose exposure and repeated insulin demand throughout the day
It may be prescribed off-label for weight management in a licensed healthcare providers sole clinical judgment
9.79 (7.3213.10) vs